跳至主要内容
临床试验/NCT03551990
NCT03551990Unknown不适用

Influence of Motor Proteins on Muscle Atrophy in Cancer Patients

University of Erlangen-Nürnberg Medical School2 个研究点 分布在 1 个国家目标入组 420 人开始时间: 2017年5月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
420
试验地点
2
主要终点
Differences in Myosin:Actin ratio

研究概览

简要总结

The aim of the study is to investigate the effect of exercise in form of whole-body electromyostimulation (WB-EMS) on early tumor-induced muscular dysfunction. It is anticipated to gain detailed knowledge about composition and metabolism of skeletal muscle cells, and single muscle fiber functionality. To determine key factors leading to impaired force generation and thus decreased muscle strength in cancer patients who are suspected to develop or already show early signs of tumor cachexia is crucial for the establishment of effective cancer treatment. Comparative analysis of skeletal muscle biopsies taken from the abdomen of patients during indicated surgeries will be conducted. The patients will be allocated to the following study groups: a) Study group 1: Patients without cancer, b) Study group 2: Patients with solid tumors who did not perform physical training and c) Study group 3: Patients with solid tumors who executed physical training in form of WB-EMS. The investigation can help to understand skeletal muscle physiology under exercise and to get a better insight into the effects of physical training on early-stage muscle atrophy, both on cellular and molecular level. Initially, it is planned to identify the inflammation and nutrition status of the patients, and to determine skeletal muscle strength. It is anticipated to explore muscle protein composition, particularly myosin to actin ratio and their interaction. Biochemical analysis and the examination of the cellular ultra-structure should enhance the knowledge about the key mechanisms controlling the contractile apparatus of single muscle fibers in order to determine the quality of muscle force. Taken together, these investigations will help to better understand muscle atrophy in advanced cancer patients, and might support the development of targeted anti-cachectic therapies, that can be applied already in early phases of the tumor disease to significantly improve the patients' prognosis and their quality of life.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients ≥ 18 years
  • Solid pancreatic, colorectal, esophageal, gastric and liver tumors under oncological treatment
  • Karnofsky performance index between 50 and 100
  • Loss of body weight (≥ 2 % and < 5 %, weight before the illness and at study entry)
  • Distinct decrease in muscle force
  • Indication for surgery proximal to the M. rectus abdominis
  • Intervention Group must have an at least 8-week waiting period until the surgery (to conduct WB-EMS)

排除标准

  • Participation in other nutrition or exercise intervention studies
  • Study-independent exercise more than once a week
  • Ingestion of anabolic or dietary supplements
  • Occurrence of heavy cardio-vascular events
  • Epilepsy and other severe neurological disorders
  • Skin lesions in the area of the electrodes
  • Conductive materials or electronical implants in the body (that do not allow electromyostimulation)
  • Pregnancy
  • Chronic diseases (e.g. HIV or Hepatitis C/D/E)
  • Rejection of a muscle biopsy

研究组 & 干预措施

Control group; patients without a tumor disease, surgery

No Intervention

Control group with patients without a tumor disease but with indication for surgery in close proximity to the M. rectus abdominis

Control group; tumor patients, surgery

No Intervention

Control group with patients with solid tumors; patients with pancreatic, colorectal, esophageal, gastric and liver solid tumors with indication for surgery in close proximity to the M. rectus abdominis

Intervention group; tumor patients, WB-EMS, surgery

Experimental

Intervention group with patients with solid tumors who do perform an 8-week physical training in form of whole-body electromyostimulation (WB-EMS); patients with pancreatic, colorectal, esophageal, gastric and liver solid tumors with indication for surgery in close proximity to the M. rectus abdominis

干预措施: whole-body electromyostimulation WB-EMS (Procedure)

结局指标

主要结局

Differences in Myosin:Actin ratio

时间窗: 8 weeks

Myosin:Actin ratio in the muscle biopsies assessed by protein analysis via Western Blotting.

Differences in cellular ultra structures

时间窗: 8 weeks

Cellular ultra structures in the muscle biopsies will be examined using multi-photon microscopy.

Differences in Force development and Calcium 2+ sensitivity of single muscle fibers

时间窗: 8 weeks

Force development and Calcium 2+ sensitivity of single muscle fibers from the muscle biopsies will be assessed by in situ biomechanical recording.

Differences in activation of involved signaling pathways

时间窗: 8 weeks

Signaling pathways that regulate muscle atrophy will be analyzed by examining protein expression and modification (Western Blotting), and gene expression (quantitative PCR) in the muscle biopsies.

Differences in Myosin isoforms

时间窗: 8 weeks

The Myosin isoforms in the muscle biopsies will be determined by protein expression analysis via Western Blotting.

次要结局

  • Differences in Nutritional risk(0 week)
  • Differences in inflammatory status(0 week)

研究者

发起方
University of Erlangen-Nürnberg Medical School
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验